ELVN Enliven Therapeutics, Inc.
Nasdaq · SEC CIK 1672619 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $76.73M 38 sales by 9 insiders
- Filings on record
- 300 since 2021-07-01, latest 2026-09-21 17:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| Derynck Mika K | Dir | — | $9.56M |
| Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| Lyssikatos Joseph P | CSO | — | $4.88M |
| Patel Anish | COO | — | $1.74M |
| Hohl Benjamin | CFO | — | $1.60M |
| Kunkel Lori Anne | Dir | — | $850.3K |
| Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| Heyman Richard A. | Dir | — | $413.4K |
Transactions 332
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-21 17:23 | 2026-09-17 | ELVN | Hohl Benjamin | CFO | M - OptEx | $14.85 | +3,982 | 44.0K | +10% | +$59.1K |
| DMT | 2026-09-21 17:23 | 2026-09-17 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $50.35 | -6,018 | 38.0K | -14% | -$303.0K |
| DT | 2026-09-21 17:22 | 2026-09-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-09-21 17:22 | 2026-09-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $50.35 | -5,000 | 25.0K | -17% | -$251.8K |
| MT | 2026-08-19 16:17 | 2026-08-17 | ELVN | Hohl Benjamin | CFO | S - Sale | $58.58 | -6,018 | 40.0K | -13% | -$352.6K |
| DT | 2026-08-19 16:16 | 2026-08-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-08-19 16:16 | 2026-08-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $58.59 | -5,000 | 25.0K | -17% | -$292.9K |
| DMT | 2026-08-06 20:18 | 2026-08-04 | ELVN | Derynck Mika K | Dir | M - OptEx | $10.84 | +158.8K | 158.8K | New | +$1.72M |
| DT | 2026-08-06 20:18 | 2026-08-04 | ELVN | Derynck Mika K | Dir | S - Sale+OE | $60.21 | -158.8K | 0 | -100% | -$9.56M |
| DT | 2026-07-21 17:24 | 2026-07-17 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,072 | 52.1K | +2% | +$2,659 |
| DMT | 2026-07-21 17:24 | 2026-07-17 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $52.64 | -6,018 | 46.1K | -12% | -$316.8K |
| DT | 2026-07-21 17:23 | 2026-07-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-07-21 17:23 | 2026-07-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $52.67 | -5,000 | 25.0K | -17% | -$263.4K |
| MT | 2026-07-08 17:15 | 2026-07-06 | ELVN | Kunkel Lori Anne | Dir | S - Sale | $50.49 | -10.0K | 41.9K | -19% | -$504.9K |
| MI | 2026-06-24 19:19 | 2026-06-22 | ELVN | ORBIMED ADVISORS LLC | 10% | S - Sale | $45.36 | -860.1K | 6.56M | -12% | -$39.01M |
| DT | 2026-06-22 17:13 | 2026-06-17 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +6,018 | 57.0K | +12% | +$14.9K |
| DMT | 2026-06-22 17:13 | 2026-06-17 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $43.80 | -6,018 | 51.0K | -11% | -$263.6K |
| DT | 2026-06-22 17:11 | 2026-06-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-06-22 17:11 | 2026-06-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $43.80 | -5,000 | 25.0K | -17% | -$219.0K |
| MI | 2026-06-17 19:45 | 2026-06-15 | ELVN | ORBIMED ADVISORS LLC | 10% | S - Sale | $45.02 | -281.4K | 7.39M | -4% | -$12.67M |
| MT | 2026-06-09 16:49 | 2026-06-05 | ELVN | Kunkel Lori Anne | Dir | S - Sale | $34.54 | -10.0K | 51.9K | -16% | -$345.4K |
| DT | 2026-05-20 16:18 | 2026-05-18 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-05-20 16:18 | 2026-05-18 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $39.79 | -5,000 | 25.0K | -17% | -$199.0K |
| DT | 2026-04-21 20:40 | 2026-04-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DMT | 2026-04-21 20:40 | 2026-04-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $47.67 | -5,000 | 25.0K | -17% | -$238.4K |
| D | 2026-03-27 | 2026-03-25 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +40.0K | 65.0K | +160% | +$99.2K |
| D | 2026-03-27 | 2026-03-25 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $35.10 | -40.0K | 25.0K | -62% | -$1.40M |
| D | 2026-03-19 | 2026-03-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $27.76 | -5,000 | 25.0K | -17% | -$138.8K |
| D | 2026-03-19 | 2026-03-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +5,000 | 30.0K | +20% | +$12.4K |
| DM | 2026-03-11 | 2026-03-09+ | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $30.06 | -40.0K | 25.0K | -62% | -$1.20M |
| DM | 2026-03-11 | 2026-03-09+ | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +40.0K | 54.9K | +269% | +$99.2K |
| 2026-03-10 | 2026-03-06 | ELVN | Hohl Benjamin | CFO | S - Sale | $29.58 | -10.0K | 51.0K | -16% | -$295.8K | |
| I | 2026-02-19 | 2026-02-17 | ELVN | Heyman Richard A. | Dir | S - Sale | $26.18 | -1,230 | 22.6K | -5% | -$32.2K |
| D | 2026-02-19 | 2026-02-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $26.17 | -45.0K | 25.0K | -64% | -$1.18M |
| D | 2026-02-19 | 2026-02-17 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +45.0K | 70.0K | +180% | +$111.6K |
| D | 2026-02-17 | 2026-02-12 | ELVN | Collins Helen Louise | Chief MEDICAL Off | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2026-02-17 | 2026-02-12 | ELVN | Hohl Benjamin | CFO | A - Grant | $0.00 | +25.0K | 61.0K | +69% | $0 |
| D | 2026-02-17 | 2026-02-12 | ELVN | Patel Anish | COO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2026-02-17 | 2026-02-12 | ELVN | Lyssikatos Joseph P | CSO | A - Grant | $0.00 | +18.8K | 18.8K | New | $0 |
| I | 2026-02-10 | 2026-02-06 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $29.04 | -5,000 | 740.2K | -0.7% | -$145.2K |
| MI | 2026-01-22 | 2026-01-20 | ELVN | Heyman Richard A. | Dir | S - Sale | $26.75 | -1,230 | 23.9K | -5% | -$32.9K |
| MI | 2026-01-22 | 2026-01-20 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $26.75 | -20.0K | 759.7K | -3% | -$535.1K |
| MI | 2026-01-13 | 2026-01-09 | ELVN | Patel Anish | COO | S - Sale | $27.98 | -48.3K | 215.3K | -18% | -$1.35M |
| MI | 2026-01-12 | 2026-01-08+ | ELVN | Heyman Richard A. | Dir | S - Sale | $25.02 | -13.9K | 25.5K | -35% | -$348.3K |
| MI | 2026-01-12 | 2026-01-08+ | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $26.23 | -132.5K | 765.2K | -15% | -$3.48M |
| D | 2025-12-23 | 2025-12-22 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +13.0K | 36.0K | +57% | +$32.2K |
| I | 2025-12-23 | 2025-12-19 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $16.84 | -5,000 | 897.7K | -0.6% | -$84.2K |
| D | 2025-12-19 | 2025-12-17 | ELVN | Kunkel Lori Anne | Dir | M - OptEx | $1.12 | +16.0K | 30.7K | +108% | +$17.9K |
| MI | 2025-12-10 | 2025-12-08 | ELVN | Patel Anish | COO | S - Sale | $21.02 | -6,663 | 263.3K | -2% | -$140.1K |
| MI | 2025-11-21 | 2025-11-19 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $22.33 | -12.5K | 902.7K | -1% | -$279.1K |
| I | 2025-11-19 | 2025-11-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.82 | -12.5K | 890.4K | -1% | -$272.8K |
| MI | 2025-11-12 | 2025-11-07 | ELVN | Patel Anish | COO | S - Sale | $17.40 | -6,667 | 270.0K | -2% | -$116.0K |
| I | 2025-10-22 | 2025-10-20 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $22.08 | -12.5K | 915.2K | -1% | -$276.0K |
| I | 2025-10-21 | 2025-10-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.33 | -12.5K | 902.9K | -1% | -$266.6K |
| I | 2025-10-09 | 2025-10-07 | ELVN | Patel Anish | COO | S - Sale | $20.10 | -6,667 | 276.6K | -2% | -$134.0K |
| D | 2025-10-01 | 2025-09-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $20.40 | -3,250 | 23.0K | -12% | -$66.3K |
| D | 2025-10-01 | 2025-09-29 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| I | 2025-09-30 | 2025-09-26 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.06 | -3,700 | 915.4K | -0.4% | -$74.2K |
| I | 2025-09-30 | 2025-09-26 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.25 | -4,000 | 927.7K | -0.4% | -$81.0K |
| I | 2025-09-25 | 2025-09-23 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.03 | -1,500 | 931.7K | -0.2% | -$30.0K |
| I | 2025-09-25 | 2025-09-23 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.03 | -2,800 | 919.1K | -0.3% | -$56.1K |
| MI | 2025-09-23 | 2025-09-19 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $19.39 | -7,000 | 933.2K | -0.7% | -$135.7K |
| MI | 2025-09-19 | 2025-09-17+ | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $19.28 | -6,000 | 922.9K | -0.6% | -$115.7K |
| I | 2025-09-10 | 2025-09-08 | ELVN | Patel Anish | COO | S - Sale | $20.24 | -6,667 | 283.3K | -2% | -$134.9K |
| D | 2025-08-29 | 2025-08-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $20.63 | -3,250 | 23.0K | -12% | -$67.0K |
| D | 2025-08-29 | 2025-08-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| MI | 2025-08-21 | 2025-08-19+ | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $19.85 | -12.5K | 940.2K | -1% | -$248.2K |
| AI | 2025-08-21 | 2025-08-20 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.00 | -1,517 | 927.9K | -0.2% | -$30.3K |
| MI | 2025-08-20 | 2025-08-18+ | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.02 | -11.0K | 929.4K | -1% | -$219.9K |
| MI | 2025-08-11 | 2025-08-07 | ELVN | Patel Anish | COO | S - Sale | $18.24 | -6,667 | 290.4K | -2% | -$121.6K |
| D | 2025-07-30 | 2025-07-28 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| DM | 2025-07-30 | 2025-07-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $20.47 | -3,250 | 23.1K | -12% | -$66.5K |
| MI | 2025-07-23 | 2025-07-21 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $22.29 | -12.5K | 952.7K | -1% | -$278.6K |
| MI | 2025-07-21 | 2025-07-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.52 | -12.5K | 940.4K | -1% | -$281.5K |
| D | 2025-07-14 | 2025-07-10 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,000 | 24.0K | +4% | +$2,480 |
| D | 2025-07-14 | 2025-07-10 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.66 | -1,000 | 23.0K | -4% | -$22.7K |
| MI | 2025-07-09 | 2025-07-07 | ELVN | Patel Anish | COO | S - Sale | $19.79 | -6,667 | 296.9K | -2% | -$132.0K |
| D | 2025-07-01 | 2025-06-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| DM | 2025-07-01 | 2025-06-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $20.91 | -3,250 | 23.0K | -12% | -$68.0K |
| I | 2025-06-24 | 2025-06-20 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $21.40 | -12.5K | 965.2K | -1% | -$267.5K |
| MI | 2025-06-18 | 2025-06-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.19 | -12.5K | 952.9K | -1% | -$277.3K |
| D | 2025-06-17 | 2025-06-13 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.55 | -3,000 | 23.0K | -12% | -$67.7K |
| D | 2025-06-17 | 2025-06-13 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,000 | 26.0K | +13% | +$7,440 |
| MI | 2025-06-11 | 2025-06-09 | ELVN | Patel Anish | COO | S - Sale | $20.34 | -6,667 | 303.4K | -2% | -$135.6K |
| I | 2025-06-05 | 2025-06-03 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.03 | -7,500 | 977.7K | -0.8% | -$150.2K |
| I | 2025-06-05 | 2025-06-03 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.05 | -7,500 | 965.4K | -0.8% | -$150.4K |
| D | 2025-05-29 | 2025-05-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| D | 2025-05-29 | 2025-05-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $16.18 | -3,250 | 23.0K | -12% | -$52.6K |
| I | 2025-05-21 | 2025-05-19 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $16.49 | -5,000 | 972.9K | -0.5% | -$82.4K |
| I | 2025-05-21 | 2025-05-19 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $16.31 | -5,000 | 985.2K | -0.5% | -$81.5K |
| MI | 2025-05-09 | 2025-05-07 | ELVN | Patel Anish | COO | S - Sale | $18.39 | -6,667 | 310.5K | -2% | -$122.6K |
| MI | 2025-05-05 | 2025-05-01+ | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.06 | -7,500 | 980.1K | -0.8% | -$150.4K |
| MI | 2025-05-05 | 2025-05-01+ | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.05 | -7,500 | 992.7K | -0.7% | -$150.4K |
| D | 2025-04-30 | 2025-04-28 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |
| DM | 2025-04-30 | 2025-04-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $18.69 | -3,250 | 23.0K | -12% | -$60.7K |
| MI | 2025-04-23 | 2025-04-21 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $16.08 | -5,000 | 998.0K | -0.5% | -$80.4K |
| I | 2025-04-21 | 2025-04-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $16.42 | -5,000 | 985.4K | -0.5% | -$82.1K |
| MI | 2025-04-09 | 2025-04-07 | ELVN | Patel Anish | COO | S - Sale | $18.04 | -6,667 | 316.8K | -2% | -$120.3K |
| D | 2025-03-31 | 2025-03-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $21.33 | -3,250 | 23.0K | -12% | -$69.3K |
| D | 2025-03-31 | 2025-03-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 26.2K | +14% | +$8,060 |